New discoveries and innovative technologies will create growth
opportunities in the in-vitro diagnostics (IVD) market with
molecular diagnostic assays set to feature strongly in the
development of personalised medicine and theranostics.
PANalytical has added a new focusing mirror to its range of PreFIX
optics that for the first time, can analyse macromolecules using a
standard, laboratory-based XRD system, rather than on a synchrotron
beam line or a single crystal...
German packaging company Gerresheimer has announced plans to take
over the pharmaceutical business of troubled Glass Group Inc (GGI)
of the US, after a Delaware bankruptcy court approved the
transaction.
Galapagos has announced that its acquisition of BioFocus' would
accelerate its transition to a fully integrated drug development
biopharmaceutical company after the two companies reached agreement
on the terms of a recommended...
Celsis International has signed a collaboration with BioVentures to
develop a microarray-based microbiological testing system to detect
contamination in pharmaceutical, biotechnology and other process
industries.
Eisai has become the first Japanese drugmaker to set up a dedicated
subsidiary in India in order to tap into local expertise in
manufacturing and research, according to local press reports.
Euroscreen has announced the issuance of a US patent, which covers
the use of a human G-protein-coupled receptor (GPCR) human P2Y13.
The patent protects screening processes using this receptor to find
compounds that modulate its activity,...
Biotrace of the UK has acquired MicroSafe Group, an Italian
supplier of microbiological testing products for the
pharmaceutical, food and defence sectors, for £2.5 million.
The consolidation in the generic pharmaceutical industry continues
apace, with companies in the easterly reaches of Europe now getting
in on the act. Czech Republic-headquartered Zentiva has signed an
agreement to acquire 51 per cent...
MerLion Pharmaceuticals has entered into a large-scale screening
programme with Cancer Research Technology (CRT) to identify new
anti-cancer drug candidates derived from natural product chemistry.
KemFine, the fine chemicals business created via a management
buyout from chemicals group Kemira last year, has acquired Avecia
Fine Chemicals' business based in Grangemouth, Scotland.
Singapore-based cleanroom specialist Esco has set up its first
direct presence in the US market via the opening of a new
subsidiary, Esco Technologies, based in Philadelphia.
UK pharmaceutical testing company Cirrus Laboratories has been
acquired by Bodycote Materials Testing, an international provider
of materials testing services to industry.
Medimmune announced the signing of an agreement to acquire
Cellective Therapeutics, in a deal that furthers its strategy of
increasing new drug candidates in its specialist areas of cancer
and autoimmune diseases such as lupus and...
Pharmaceutical companies are increasingly looking to retain their
internal focus on research and development (R&D) and marketing
while outsourcing their manufacturing processes, thus fueling a
growing demand for the manufacturing...
